Shanghai Pudong: Boosting Global Premieres of Imported Innovative Drugs and Fostering Local Production of 100 Imported Products
2025-07-24 / Read about 0 minute
Author:小编   

The Shanghai Pudong New Area has unveiled a comprehensive plan to elevate the capabilities of its biomedicine industrial park. This initiative aims to incentivize foreign-invested enterprises to expand their industrial chain footprint, facilitating the synchronized research and development (R&D), clinical trials, application, and market launch of imported innovative drugs. The plan underscores the importance of enhancing management and services for pivotal foreign-invested projects, with an ambitious objective of fostering the development of over five key projects and achieving the local manufacturing of 100 imported products.